Mounjaro (Tirzepatide): Diabetes & Weight Loss Medication

Mounjaro, the brand name of Tirzepatide, is a groundbreaking medication widely recognized for its effectiveness in managing Type 2 diabetes and promoting significant weight loss. Mounjaro is administered as a weekly injection.

The currently available formulations in Thailand include Mounjaro 2.5 mg, 5 mg, 7.5 mg, and 10 mg pens. It’s a multi-dose, pre-filled pen designed for four injections per pen. This format offers a convenient and effective solution for those seeking weight loss injection therapy or support with diabetic control.

As of now, Mounjaro (Tirzepatide) is fully approved by the Thai FDA and distributed through licensed clinics and hospitals, including H.U.M. Clinic in Bangkok. Whether you’re exploring Mounjaro injections for its dual benefits or starting a prescription-based weight loss plan, we provide expert consultation and personalized treatment to help you achieve your health and wellness goals.

What Is Mounjaro (Tirzepatide) and How Does It Work?

Mounjaro, (Tirzepatide) is a dual-acting glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) receptor agonist. Both are gut hormones that regulate blood sugar and appetite. Approved by the FDA, it‘s primarily used for Type 2 diabetes management and has shown exceptional results in weight loss treatments, especially for overweight and obese patients.

Mounjaro enhances insulin sensitivity and suppresses appetite by targeting GIP and GLP-1 receptors. Activating GIP and GLP-1 receptors together helps your pancreas release insulin when blood sugar is high, slows how quickly food leaves your stomach, and turns down your appetite. The slower digestion is part of why people taking it tend to feel full faster and stay satiated longer.

This dual mechanism helps regulate blood sugar, reduce calorie intake, and promote significant weight reduction, making it a preferred option for patients needing metabolic improvements.

Mounjaro: Medical Uses

Mounjaro (Tirzepatide) offers dual benefits for managing Type 2 diabetes and supporting weight loss, making it a versatile option for individuals seeking metabolic improvements and better health outcomes.

Mounjaro for Type 2 Diabetes Management

For people with Type 2 diabetes, a condition in which blood glucose levels are too high because the body does not use insulin effectively, Mounjaro improves glycemic control by lowering blood sugar and reducing HbA1c. Studies show that it significantly improves insulin sensitivity, making it highly effective for individuals with Type 2 diabetes struggling with traditional treatments. It is typically added when diet, exercise, and other medications have not brought blood sugar into a healthy range on their own.

Mounjaro as a Weight Loss Treatment

Beyond diabetes management, Mounjaro is proven to aid in substantial weight loss. Clinical trials report significant reductions in body weight for overweight and obese patients. Mounjaro improves overall health and reduces obesity-related risks. Patients in Thailand can get a Mounjaroprescription in Bangkok through a doctor consultation at H.U.M. Clinic. Results vary from person to person, and Mounjaro works best alongside changes to diet and activity.

Mounjaro: Dosage and Administration

Mounjaro (Tirzepatide) is administered as a once-weekly injection. When using Mounjaro for diabetes management and weight loss, proper dosing and administration are essential to maximize its benefits.

Recommended Mounjaro Dosage

• Starting dose: The typical starting Mounjaro dose is 2.5 mg once weekly.
• After 4 weeks: The Mounjaro dose increases to 5 mg weekly, then rises in 2.5 mg increments no more often than every 4 weeks if additional control is needed.
• Mounjaro doses can be titrated to 5 mg, 7.5mg, 10 mg, 12mg, or 15 mg for adults. Maximum dose: The 15 mg dosage is the maximum dose. The dose is gradually increased based on individual tolerance and treatment goals.

Mounjaro: Administration Instructions

Mounjaro injection is given subcutaneously in the abdomen, thigh, or upper arm. This means it goes into the fatty tissue just under the skin, rather than the muscle. Rotating injection sites helps avoid irritation.

Store the medication in the refrigerator until you need it. Follow your doctor’s instructions to ensure proper injection techniques for safety and effectiveness. Once a multi-dose Mounjaro injection pen is in use, store it in the refrigerator or at room temperature (up to 30 °C), and discard it after 30 days, or after your fourth weekly dose from that pen. whichever is first.

Mounjaro: Safety and Precautions

Mounjaro is contraindicated in people with:

• A personal or family history of MTC (Medullary Thyroid Carcinoma) or MEN 2 (Multiple Endocrine Neoplasia syndrome type 2).
• Known allergies to any ingredient of Mounjaro.
• Individuals with type 1 diabetes
• Children under 18 years.

Before starting Mounjaro injections, inform your healthcare provider if you:

• Are pregnant, plan to become pregnant, or are breastfeeding.
• Have a history of pancreatitis, kidney issues, or severe stomach problems like gastroparesis.
• Take medications that affect blood sugar, including insulin or sulfonylureas.
• Use oral birth control pills, as Mounjaro may reduce their effectiveness. Alternative contraception is recommended for at least four weeks after starting or adjusting Mounjaro doses.

Mounjaro Side Effects

While Mounjaro (Tirzepatide) is highly effective, it is important to be aware of potential side effects and take necessary precautions to ensure safe use.

Common Side Effects of Mounjaro

Most users experience mild side effects from taking Mounjaro, including:

• Nausea
• Diarrhea
• Decreased appetite
• Vomiting
• Constipation
• Indigestion
• Abdominal pain

These side effects are typically temporary and subside as your body adjusts to the medication. Taking your Mounjaro injection with a light meal and staying hydrated can help make the first few weeks more comfortable. However, report any persistent or bothersome effects to your healthcare provider.

Serious Side Effects

Mounjaro may cause severe side effects, including:

• Thyroid Tumors: Mounjaro has been associated with thyroid tumors, including thyroid cancer. If you notice a lump, swelling in the neck, hoarseness, trouble swallowing, or shortness of breath, contact your doctor immediately.
• Pancreatitis: Stop usage and seek medical attention if you experience severe, persistent abdominal pain that may radiate to your back, with or without vomiting.
• Hypoglycemia (Low Blood Sugar): If combined with insulin or sulfonylureas, Mounjaro may increase the risk of low blood sugar, which can cause dizziness, sweating, and weakness.
• Gallbladder Problems: Symptoms such as pain in the upper abdomen, yellowing of the skin or eyes, and clay-colored stools should be reported promptly.
• Kidney Problems: Dehydration from nausea, vomiting, or diarrhea may worsen kidney function. Ensure proper hydration during treatment.
• Diabetic retinopathy progression. If you already have diabetic eye disease, your doctor may monitor it more closely while you are on Mounjaro.
• Hypersensitivity reactions. Serious allergic reactions, including anaphylaxis and swelling of the face or throat, require stopping the medication and seeking care right away.
• Pulmonary aspiration risk during surgery. Because Mounjaro slows digestion, tell any surgeon or anesthesiologist that you’re taking it before any planned procedure under sedation or general anesthesia.

Mounjaro vs. Other GLP-1 Medications

Mounjaro (Tirzepatide) stands out among GLP-1 receptor agonists for its unique dual action. How does it compare to similar medications like Semaglutide and Liraglutide?

Mounjaro vs. Semaglutide (Ozempic and Wegovy)

Both Tirzepatide and Semaglutide offer exceptional glycemic control and weight loss benefits. However, clinical trials show Mounjaro achieving greater weight loss and HbA1c reduction. Mounjaro’s dual GIP/GLP-1 mechanism provides an edge, but Semaglutide remains a strong single-action alternative.

Mounjaro vs. Liraglutide (Victoza and Saxenda)

Mounjaro requires only a once-weekly injection, compared to Liraglutide’s daily dosing. Its dual-action mechanism leads to better weight loss and glycemic outcomes. Liraglutide, however, may still be preferred for patients requiring more frequent, gradual adjustments.

Why Choose H.U.M. Clinic for Mounjaro?

Mounjaro (Tirzepatide) is now officially available in Thailand, including at H.U.M. Clinic in Bangkok, in 2.5 mg and 5 mg pens. We also offer higher doses, providing scalable treatment options for effective weight loss injection therapy.

At H.U.M. Clinic, all medications, including Mounjaro, are FDA-approved. We prioritize patient safety and authenticity by sourcing directly from licensed pharmaceutical supplier Zuellig Pharma, the official distributor of Eli Lilly in Thailand. In line with international standards, our clinic ensures that every patient receives medically supervised care with verified, high-quality medication.

Our team specializes in diabetes and weight loss treatments, providing tailored therapy for effective outcomes. Regular monitoring ensures your treatment is both safe and optimized for your unique needs. We also provide nutritional counseling and regular follow-ups to help you achieve and sustain your health goals. Our holistic approach ensures comprehensive care throughout your journey. Contact us to book an appointment, create a personalized treatment plan, or buy Mounjaro in Bangkok.

Frequently Asked Questions About Mounjaro

Q: Is Mounjaro effective for prediabetes management?

A: While Tirzepatide is not officially approved for prediabetes, its ability to regulate blood sugar levels and improve insulin sensitivity makes it a promising option for early intervention. Consult a healthcare provider for personalized advice.

Q: Can Mounjaro be used with other diabetes medications?

A: Yes, Tirzepatide can be combined with other diabetes treatments like metformin or insulin. However, combining therapies may increase the risk of hypoglycemia (low blood sugar), so monitoring and adjustments by a doctor are essential.

Q: Is Mounjaro safe for patients with heart disease?

A: Tirzepatide has shown potential benefits for cardiovascular health by aiding weight loss and improving metabolic profiles. However, patients with a history of heart disease should consult their doctor to evaluate potential risks.

Q: Can I stop taking Mounjaro after achieving my weight loss goal?

A: Discontinuing the medication may lead to weight regain. Long-term use may be required to maintain results. Always discuss any changes to your treatment plan with your healthcare provider.

Q: How should I store Mounjaro?

A: Tirzepatide should be stored in the refrigerator at 2°C to 8°C (36°F to 46°F). After first use, it can be stored unrefrigerated below 30°C (86°F) for up to 30 days. Discard the pen 30days after first use.

Q: Who should not use Mounjaro?

A: Tirzepatide is not recommended for individuals with a history of medullary thyroid carcinoma (MTC), Multiple Endocrine Neoplasia syndrome Type 2 (MEN 2), or severe gastroparesis. Always consult your doctor before starting treatment.